SciSparc

SciSparc

Pharmaceuticals
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company’s operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

$2.9M

Market Cap • 9/11/2026

2004

(22 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Israel

Israel

Country

Valuation

P/B

0,7

P/S

3,4

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

34,1

EPS

Market Cap

Market Cap

2,9M

EV

-416,3K

EV/Revenue

-0,5

EV/EBITDA

0

EV/EBIT

0

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-116,2%

Total Yield

-116,2%

Payout

0%

Retained Earnings

-87,2M

Profitability

Gross Margin

73,7%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

245%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

% PPE

0,2%

% Goodwill

0%

ROE

ROIC

Growth

CAGR Op. Income 5Y

28,3%

CAGR Net Income 5Y

28,9%

CAGR OCF 5Y

-0,8%

Leverage

N.D./EBITDA

0,5

Debt/Equity

0%

Current Ratio

2,4

Quick Ratio

2,4

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium